Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1Y18
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,935
Award facts
- Contract value 100% obligated
- $16,935.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,935.48 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 ml auto-injector pens. This firm fixed-price contract, issued on January 28, 2026, with an ultimate completion date of January 29, 2026, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The current order for Actemra, a biologic immunosuppressant used in treating rheumatoid arthritis and other inflammatory conditions, reflects the company's role in providing critical pharmaceutical support to Department of Defense and related federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F1Y18?
SPE2DR26F1Y18 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1Y18 worth?
The government has obligated $16,935 on SPE2DR26F1Y18.
Is contract SPE2DR26F1Y18 an order under another contract?
Yes. SPE2DR26F1Y18 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Y18 competed?
The extent of competition for SPE2DR26F1Y18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award